BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17934822)

  • 21. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis.
    Wouters MM; Van Wanrooy S; Nguyen A; Dooley J; Aguilera-Lizarraga J; Van Brabant W; Garcia-Perez JE; Van Oudenhove L; Van Ranst M; Verhaegen J; Liston A; Boeckxstaens G
    Gut; 2016 Aug; 65(8):1279-88. PubMed ID: 26071133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?
    Svendsen AT; Bytzer P; Engsbro AL
    Scand J Gastroenterol; 2019 May; 54(5):546-562. PubMed ID: 31112663
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-infectious irritable bowel syndrome following water contamination.
    Marshall JK
    Kidney Int Suppl; 2009 Feb; (112):S42-3. PubMed ID: 19180133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.
    Pike BL; Paden KA; Alcala AN; Jaep KM; Gormley RP; Maue AC; Christmann BS; Elson CO; Riddle MS; Porter CK
    J Travel Med; 2015; 22(4):242-50. PubMed ID: 26058758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter jejuni gastroenteritis complicated by pancytopenia.
    Rai B; Ray R
    Indian Pediatr; 2014 Jun; 51(6):505. PubMed ID: 24986300
    [No Abstract]   [Full Text] [Related]  

  • 28. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myocarditis secondary to acute
    Greenfield GM; Mailey J; Lyons K; Trouton TG
    Clin Med (Lond); 2018 Feb; 18(1):98-99. PubMed ID: 29436448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens.
    Grover M; Camilleri M; Smith K; Linden DR; Farrugia G
    Neurogastroenterol Motil; 2014 Feb; 26(2):156-67. PubMed ID: 24438587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
    Haagsma JA; Siersema PD; De Wit NJ; Havelaar AH
    Epidemiol Infect; 2010 Nov; 138(11):1650-6. PubMed ID: 20223049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current Status of Translational Research on Irritable Bowel Syndrome].
    Kwon YH; Kim HJ
    Korean J Gastroenterol; 2016 Sep; 68(3):138-42. PubMed ID: 27646582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.
    Neal KR; Hebden J; Spiller R
    BMJ; 1997 Mar; 314(7083):779-82. PubMed ID: 9080994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is irritable bowel syndrome an inflammatory disorder?
    De Giorgio R; Barbara G
    Curr Gastroenterol Rep; 2008 Aug; 10(4):385-90. PubMed ID: 18627650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campylobacter jejuni Infections: update on emerging issues and trends.
    Allos BM
    Clin Infect Dis; 2001 Apr; 32(8):1201-6. PubMed ID: 11283810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postinfectious Irritable Bowel Syndrome After Campylobacter Infection.
    Scallan Walter EJ; Crim SM; Bruce BB; Griffin PM
    Am J Gastroenterol; 2019 Oct; 114(10):1649-1656. PubMed ID: 31567167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of infection in irritable bowel syndrome.
    Spiller RC
    J Gastroenterol; 2007 Jan; 42 Suppl 17():41-7. PubMed ID: 17238025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term and medium-term clinical outcomes of Campylobacter concisus infection.
    Nielsen HL; Engberg J; Ejlertsen T; Bücker R; Nielsen H
    Clin Microbiol Infect; 2012 Nov; 18(11):E459-65. PubMed ID: 22882347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R; Savarese MF; Gargano R
    Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis.
    Verdu EF; Mauro M; Bourgeois J; Armstrong D
    Can J Gastroenterol; 2007 Jul; 21(7):453-5. PubMed ID: 17637949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.